NCT01385527WithdrawnNot Applicable
Using an Internet Survey to Improve Adherence in Pediatric Atopic Dermatitis
Conditions
Interventions
Drugs
Trial Snapshot
- Phase
- Not Applicable
- Status
- Withdrawn
- Sponsor
- Wake Forest University
- Primary Endpoint
- Adherence to topical triamcinolone
Study Overview
Brief Summary
The purpose of this study is to evaluate whether participation in an Internet-based intervention helps improve atopic dermatitis treatment outcomes.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Health Services Research
- Masking
- Triple (Care Provider, Investigator, Outcomes Assessor)
Eligibility Criteria
- Ages
- 2 Years to 8 Years (Child)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Any child age 2 to 8 with a diagnosis of atopic dermatitis confirmed by a dermatologist, together with the child's parent/guardian. Written consent must be given by parent/guardian.
Exclusion Criteria
- •Child is less than 2 or greater than 8 years of age.
- •Known allergy or sensitivity to topical triamcinolone in the child.
- •Inability to complete all study-related visits, or inability to complete the Internet survey due to inadequate Internet access.
- •Introduction of any other prescription medication, topical or systemic, for atopic dermatitis while participating in the study. Subjects who are on systemic anti-inflammatory treatments for atopic dermatitis must be on a stable dose for at least 3 months prior to enrollment.
Arms & Interventions
Weekly Internet survey w medication
Experimental
Weekly survey via email plus topical triamcinolone
Intervention: Weekly Internet survey (Behavioral)
Weekly Internet survey w medication
Experimental
Weekly survey via email plus topical triamcinolone
Intervention: Topical Triamcinolone (Drug)
Topical triamcinolone only
Active Comparator
Standard of care
Intervention: Topical Triamcinolone (Drug)
Outcomes
Primary Outcomes
Adherence to topical triamcinolone
Time Frame: 12 weeks
Secondary Outcomes
- Eczema Area Severity Index(12 weeks)
- Investigator's Global Assessment(12 weeks)
Investigators
Similar Trials
Completed
Not Applicable
The Medication Experience StudyElevated CholesterolDiabetesHypertensionDepressionNCT01702883Wake Forest University186
Completed
Early Phase 1
Using an Internet Study to Improve Adherence for Psoriasis PatientsPsoriasisNCT01802580Wake Forest University40
Completed
Phase 1
Enhancing Adherence by Building Online CommunitiesObesityType 2 DiabetesCoronary Artery DiseaseNCT00729040Robert Wood Johnson Foundation324
Completed
Not Applicable
Therapy Labs: To Improve Adherence in Internet Based PsychotherapyBehavior TherapyNCT02535598Uppsala University169
Completed
Phase 2
Evaluation of an Internet-based Intervention for Hazardous DrinkersHazardous Alcohol ConsumptionNCT01075685Institut national de prevention et d'education pour la sante1,157